383 related articles for article (PubMed ID: 3969067)
1. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
2. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
Leff SE; Hamblin MW; Creese I
Mol Pharmacol; 1985 Feb; 27(2):171-83. PubMed ID: 3969066
[TBL] [Abstract][Full Text] [Related]
3. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
4. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
5. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
Sibley DR; Creese I
Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
[TBL] [Abstract][Full Text] [Related]
6. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
Hamblin MW; Leff SE; Creese I
Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
[TBL] [Abstract][Full Text] [Related]
7. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
8. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
10. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
Wreggett KA; Seeman P
Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
[TBL] [Abstract][Full Text] [Related]
11. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
Munemura M; Agui T; Sibley DR
Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
Zahniser NR; Molinoff PB
Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
[TBL] [Abstract][Full Text] [Related]
13. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
Hensler JG; Cotterell DJ; Dubocovich ML
J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
16. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
17. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
18. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
[TBL] [Abstract][Full Text] [Related]
19. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
Nakajima T; Iwata K
Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
[TBL] [Abstract][Full Text] [Related]
20. Expression and pharmacological characterization of the human D3 dopamine receptor.
Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G
J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
